Literature DB >> 21635914

Chronic cocaine self-administration attenuates the anxiogenic-like and stress potentiating effects of the benzodiazepine inverse agonist, FG 7142.

R Parrish Waters1, Ronald E See.   

Abstract

Stress is a well-known risk factor in relapse to drug abuse. Several forms of stress in animals have been used with varied degrees of success to elicit reinstatement of drug-seeking after chronic drug self-administration. Here, we tested the ability of the benzodiazepine (BZ) inverse agonist, FG 7142, to elicit anxiety-like behavior and potentiate stress responses in rats as measured by standard behavioral and hormonal indices and for its ability to affect reinstatement of cocaine-seeking in rats with a prior history of cocaine self-administration. FG 7142 elicited anxiety-like behavior on the elevated plus maze (EPM) in cocaine-naïve rats, and cocaine-naïve rats injected with FG 7142 exhibited increased plasma corticosterone levels following EPM exposure. However, in animals with a history of cocaine self-administration, FG 7142 failed to affect elevated plus maze performance and did not affect plasma corticosterone response to the EPM. Furthermore, FG 7142 failed to reinstate cocaine-seeking, nor did it alter conditioned cue-induced reinstatement. These data indicate that the anxiety-related and stress potentiating qualities of BZ inverse agonism are attenuated in cocaine-experienced animals and do not lead to reinstatement of cocaine-seeking.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21635914      PMCID: PMC3129491          DOI: 10.1016/j.pbb.2011.05.021

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  60 in total

Review 1.  Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure.

Authors:  David H Epstein; Kenzie L Preston; Jane Stewart; Yavin Shaham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-22       Impact factor: 4.530

Review 2.  Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking.

Authors:  Uri Shalev; Suzanne Erb; Yavin Shaham
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

3.  Footshock-induced freezing behavior in rats as a model for assessing anxiolytics.

Authors:  L H Conti; C R Maciver; J W Ferkany; M E Abreu
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Effect of diazepam and A beta-carboline on open-field and T-maze behaviors in 2-day-old chicks.

Authors:  R H Marín; I D Martijena; A Arce
Journal:  Pharmacol Biochem Behav       Date:  1997-12       Impact factor: 3.533

5.  Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.

Authors:  M J Millan; A Newman-Tancredi; V Audinot; D Cussac; F Lejeune; J P Nicolas; F Cogé; J P Galizzi; J A Boutin; J M Rivet; A Dekeyne; A Gobert
Journal:  Synapse       Date:  2000-02       Impact factor: 2.562

6.  Corticotropin releasing factor produces behavioural activation in rats.

Authors:  R E Sutton; G F Koob; M Le Moal; J Rivier; W Vale
Journal:  Nature       Date:  1982-05-27       Impact factor: 49.962

7.  Role of dorsal medial prefrontal cortex dopamine D1-family receptors in relapse to high-fat food seeking induced by the anxiogenic drug yohimbine.

Authors:  Sunila G Nair; Brittany M Navarre; Carlo Cifani; Charles L Pickens; Jennifer M Bossert; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2010-10-20       Impact factor: 7.853

8.  A role for the bed nucleus of the stria terminalis, but not the amygdala, in the effects of corticotropin-releasing factor on stress-induced reinstatement of cocaine seeking.

Authors:  S Erb; J Stewart
Journal:  J Neurosci       Date:  1999-10-15       Impact factor: 6.167

9.  Postnatal cocaine exposure: effects on behavior of rats in forced swim test.

Authors:  Ana Magalhães; Maria Amélia Tavares; Liliana de Sousa
Journal:  Ann N Y Acad Sci       Date:  2002-06       Impact factor: 5.691

Review 10.  Pharmacology of the beta-carboline FG-7,142, a partial inverse agonist at the benzodiazepine allosteric site of the GABA A receptor: neurochemical, neurophysiological, and behavioral effects.

Authors:  Andrew K Evans; Christopher A Lowry
Journal:  CNS Drug Rev       Date:  2007
View more
  5 in total

1.  Repeated crack cocaine administration alters panic-related responses and delta FosB immunoreactivity in panic-modulating brain regions.

Authors:  Barbara Dos Anjos Rosário; Maria de Fátima Santana de Nazaré; Jéssica Alves Lemes; José Simões de Andrade; Regina Barbosa da Silva; Camilo Dias Seabra Pereira; Daniel Araki Ribeiro; Milena de Barros Viana
Journal:  Exp Brain Res       Date:  2021-02-10       Impact factor: 1.972

Review 2.  Stress-Induced Reinstatement of Drug Seeking: 20 Years of Progress.

Authors:  John R Mantsch; David A Baker; Douglas Funk; Anh D Lê; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2015-05-15       Impact factor: 7.853

3.  Modulation of relapse-like drinking in male Sprague-Dawley rats by ligands targeting the α5GABAA receptor.

Authors:  Cassie M Chandler; Jaren Reeves-Darby; Sherman A Jones; Guanguan Li; Md T Rahman; James M Cook; Donna M Platt
Journal:  Neuropharmacology       Date:  2021-09-10       Impact factor: 5.250

4.  Dissociation Between Incubation of Cocaine Craving and Anxiety-Related Behaviors After Continuous and Intermittent Access Self-Administration.

Authors:  Celine Nicolas; Trinity I Russell; Yavin Shaham; Satoshi Ikemoto
Journal:  Front Neurosci       Date:  2022-02-07       Impact factor: 4.677

5.  High anxiety is a predisposing endophenotype for loss of control over cocaine, but not heroin, self-administration in rats.

Authors:  Ruth Dilleen; Yann Pelloux; Adam C Mar; Anna Molander; Trevor W Robbins; Barry J Everitt; Jeffrey W Dalley; David Belin
Journal:  Psychopharmacology (Berl)       Date:  2012-01-14       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.